These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31632062)

  • 1. PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway.
    Gu J; Zhang Z; Lang T; Ma X; Yang L; Xu J; Tian C; Han K; Qiu J
    Onco Targets Ther; 2019; 12():8095-8104. PubMed ID: 31632062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1.
    Tian C; Lang T; Qiu J; Han K; Zhou L; Min D; Zhang Z; Qi D
    Cancer Cell Int; 2020 Dec; 20(1):579. PubMed ID: 33292299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway.
    Zhang H; Lang TY; Zou DL; Zhou L; Lou M; Liu JS; Li YZ; Ding DY; Li YC; Zhang N; Zheng XD; Zeng XH; Zhou Q; Li L
    Onco Targets Ther; 2019; 12():11691-11700. PubMed ID: 32021247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway.
    Zhao N; Zhou L; Lu Q; Wang S; Sun Y; Ding Y; Liu M; He H; Lang T
    Exp Eye Res; 2022 Jan; 214():108887. PubMed ID: 34890603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARF, As An Oncogene, Promotes Colorectal Cancer Stemness By Activating ERBB Signaling Pathway.
    Dong W; Cao Z; Pang Y; Feng T; Tian H
    Onco Targets Ther; 2019; 12():9041-9051. PubMed ID: 31802911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalin Attenuates YAP Activity to Suppress Ovarian Cancer Stemness.
    Li Y; Wang D; Liu J; Li Y; Chen D; Zhou L; Lang T; Zhou Q
    Onco Targets Ther; 2020; 13():7151-7163. PubMed ID: 32801747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 8. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
    Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
    J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling.
    Wang H; Feng W; Chen W; He J; Min J; Liu Y; Li F; Chen J; Wu S; Chen B; Gong A; Xu M
    Exp Cell Res; 2020 Aug; 393(1):112091. PubMed ID: 32422133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ethyl acetate extract from Celastrus orbiculatus suppresses non-small-cell lung cancer by activating Hippo signaling and inhibiting YAP nuclear translocation.
    Jin F; Ni X; Yu S; Jiang X; Shi X; Zhou J; Mao D; Wang H; Liu Y; Wu F
    Phytomedicine; 2023 Jun; 114():154761. PubMed ID: 37028249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of protein tyrosine phosphatase receptor U inhibits growth and motility of gastric cancer cells.
    Liu Y; Zhu Z; Xiong Z; Zheng J; Hu Z; Qiu J
    Int J Clin Exp Pathol; 2014; 7(9):5750-61. PubMed ID: 25337216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFATC2 is a novel therapeutic target for colorectal cancer stem cells.
    Lang T; Ding X; Kong L; Zhou X; Zhang Z; Ju H; Ding S
    Onco Targets Ther; 2018; 11():6911-6924. PubMed ID: 30410349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-103a Curtails the Stemness of Non-Small Cell Lung Cancer Cells by Binding OTUB1 via the Hippo Signaling Pathway.
    Hu Z; Xiao D; Qiu T; Li J; Liu Z
    Technol Cancer Res Treat; 2020; 19():1533033820971643. PubMed ID: 33174524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells.
    Gao F; Yu X; Meng R; Wang J; Jia L
    Onco Targets Ther; 2018; 11():5371-5381. PubMed ID: 30214243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc finger and SCAN domain containing 1, ZSCAN1, is a novel stemness-related tumor suppressor and transcriptional repressor in breast cancer targeting TAZ.
    Chu J; Li Y; He M; Zhang H; Yang L; Yang M; Liu J; Cui C; Hong L; Hu X; Zhou L; Li T; Li C; Fan H; Jiang G; Lang T
    Front Oncol; 2023; 13():1041688. PubMed ID: 36923432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
    Li T; Guo T; Liu H; Jiang H; Wang Y
    Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA B4GALT1-AS1 promotes colon cancer cell stemness and migration by recruiting YAP to the nucleus and enhancing YAP transcriptional activity.
    Zhang Y; Fang Z; Guo X; Dong H; Zhou K; Huang Z; Xiao Z
    J Cell Physiol; 2019 Aug; 234(10):18524-18534. PubMed ID: 30912138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.
    Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS
    Front Oncol; 2019; 9():60. PubMed ID: 30805310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.